D.E. Shaw & Co
HSTO

D.E. Shaw & Co’s Histogen Inc. Common Stock HSTO Stock Holding History

D.E. Shaw & Co’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-257
Closed -$13K – 4092
2019
Q2 		$13K Sell
257
-181
-41% -$31.4K ﹤0.01% 3625
2019
Q1 		$95K Buy
438
+127
+41% +$51.2K ﹤0.01% 3482
2018
Q4 		$108K Buy
311
+104
+50% +$80.8K ﹤0.01% 3633
2018
Q3 		$240K Sell
207
-126
-38% -$116K ﹤0.01% 3461
2018
Q2 		$285K Buy
333
+178
+115% +$148K ﹤0.01% 3400
2018
Q1 		$182K Sell
155
-72
-32% -$79.6K ﹤0.01% 3344
2017
Q4 		$210K Buy
227
+171
+305% +$158K ﹤0.01% 3420
2017
Q3 		$62K Buy
+56
New +$63.7K ﹤0.01% 3394
2016
Q4 		– Sell
-439
Closed -$175K – 3670
2016
Q3 		$175K Buy
439
+213
+94% +$86.9K ﹤0.01% 3221
2016
Q2 		$93K Buy
226
+146
+183% +$71.5K ﹤0.01% 3259
2016
Q1 		$34K Sell
80
-234
-75% -$90.4K ﹤0.01% 3348
2015
Q4 		$181K Buy
+314
New +$220K ﹤0.01% 3584
2015
Q3 		– Sell
-87
Closed -$90K – 3970
2015
Q2 		$90K Buy
+87
New +$102K ﹤0.01% 3660

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KM
Kalos Management Alpharetta, Georgia $46.6M AUM 11.52% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

D.E. Shaw & Co's HSTO Position: Q3 2019 in Review

D.E. Shaw & Co sold out of Histogen Inc. Common Stock (HSTO) in Q3 2019, closing a stake of 257 shares — an estimated $13K sold.

D.E. Shaw & Co first reported a position in HSTO in Q2 2015 and held it in 13 quarters. The position peaked at $285K in Q2 2018. 29 funds tracked by Wall St. Rank hold HSTO as of Q3 2019.

  • D.E. Shaw & Co reported no remaining Histogen Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 257 Histogen Inc. Common Stock shares in Q3 2019, an estimated $13K.
  • D.E. Shaw & Co first reported a position in Histogen Inc. Common Stock in Q2 2015 and held it in 13 quarters.
  • D.E. Shaw & Co's Histogen Inc. Common Stock position peaked at $285K in Q2 2018.
  • 29 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2019.

Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.